Detalles de la búsqueda
1.
Single-Cell Analysis of Crohn's Disease Lesions Identifies a Pathogenic Cellular Module Associated with Resistance to Anti-TNF Therapy.
Cell
; 178(6): 1493-1508.e20, 2019 09 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-31474370
2.
Microbiotas from Humans with Inflammatory Bowel Disease Alter the Balance of Gut Th17 and RORγt+ Regulatory T Cells and Exacerbate Colitis in Mice.
Immunity
; 50(1): 212-224.e4, 2019 01 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-30650377
3.
Mirikizumab as Induction and Maintenance Therapy for Ulcerative Colitis.
N Engl J Med
; 388(26): 2444-2455, 2023 Jun 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-37379135
4.
Etrasimod as induction and maintenance therapy for ulcerative colitis (ELEVATE): two randomised, double-blind, placebo-controlled, phase 3 studies.
Lancet
; 401(10383): 1159-1171, 2023 04 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-36871574
5.
Long-Term Effectiveness and Durability of COVID-19 Vaccination Among Patients With Inflammatory Bowel Disease.
Clin Gastroenterol Hepatol
; 2024 Feb 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-38369224
6.
Determining the Accuracy of Intestinal Ultrasound Scores as a Prescreening Tool in Crohn's Disease Clinical Trials.
Am J Gastroenterol
; 119(5): 930-936, 2024 May 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-38131626
7.
Changes in Therapy Are Not Associated With Increased Remission in Patients With Crohn's Disease of the Pouch.
Am J Gastroenterol
; 2024 Feb 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-37975591
8.
Humoral immune response and safety of SARS-CoV-2 vaccination in very early onset inflammatory bowel disease.
J Pediatr Gastroenterol Nutr
; 78(4): 871-877, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38356293
9.
Real-World Outcomes of Dual Advanced Therapy in Children and Young Adults with Inflammatory Bowel Disease.
Dig Dis Sci
; 69(5): 1826-1833, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38521850
10.
Patient and Health Care Professional Perceptions of the Experience and Impact of Symptoms of Moderate-to-Severe Crohn's Disease in US and Europe: Results from the Cross-Sectional CONFIDE Study.
Dig Dis Sci
; 2024 May 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-38700629
11.
Low-Dose Aspirin Use Does Not Increase Disease Activity in Pregnant Patients with Inflammatory Bowel Disease.
Dig Dis Sci
; 69(5): 1803-1807, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38493274
12.
Biopsy and blood-based molecular biomarker of inflammation in IBD.
Gut
; 72(7): 1271-1287, 2023 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-36109152
13.
Risankizumab as maintenance therapy for moderately to severely active Crohn's disease: results from the multicentre, randomised, double-blind, placebo-controlled, withdrawal phase 3 FORTIFY maintenance trial.
Lancet
; 399(10340): 2031-2046, 2022 05 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-35644155
14.
Risankizumab as induction therapy for Crohn's disease: results from the phase 3 ADVANCE and MOTIVATE induction trials.
Lancet
; 399(10340): 2015-2030, 2022 05 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-35644154
15.
Early Biologic Initiation After Chronic Pouch Inflammation Diagnosis Does Not Impact Clinical Outcomes.
Clin Gastroenterol Hepatol
; 21(2): 541-542.e1, 2023 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-35123095
16.
Combination Therapy With Immunomodulators Improves the Pharmacokinetics of Infliximab But Not Vedolizumab or Ustekinumab.
Clin Gastroenterol Hepatol
; 21(11): 2908-2917.e10, 2023 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-36280102
17.
Upadacitinib Therapy Reduces Ulcerative Colitis Symptoms as Early as Day 1 of Induction Treatment.
Clin Gastroenterol Hepatol
; 21(9): 2347-2358.e6, 2023 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-36464141
18.
Integrative Analysis of the Inflammatory Bowel Disease Serum Metabolome Improves Our Understanding of Genetic Etiology and Points to Novel Putative Therapeutic Targets.
Gastroenterology
; 162(3): 828-843.e11, 2022 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-34780722
19.
CORE-IBD: A Multidisciplinary International Consensus Initiative to Develop a Core Outcome Set for Randomized Controlled Trials in Inflammatory Bowel Disease.
Gastroenterology
; 163(4): 950-964, 2022 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-35788348
20.
Higher Postinduction Infliximab Concentrations Are Associated With Favorable Clinical Outcomes in Pediatric Crohn's Disease: A Post Hoc Analysis of the REACH Trial.
Am J Gastroenterol
; 118(3): 485-490, 2023 03 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36624036